Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study

The occurrence of irAEs is associated with improved response and survival, whereas ILD may not reflect antitumor immunity. These findings emphasize the need for detailed toxicity profiling when interpreting irAEs as potential biomarkers in immunotherapy.